Open Access. Powered by Scholars. Published by Universities.®

Other Medical Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 5 of 5

Full-Text Articles in Other Medical Sciences

Dnp Final Report: Breaking The Cycle: Care Coordination Interventions And Sickle Cell Readmissions, Naphtali Edge Feb 2021

Dnp Final Report: Breaking The Cycle: Care Coordination Interventions And Sickle Cell Readmissions, Naphtali Edge

DNP Final Reports

Background

Approximately 100,000 people in the United States are affected by Sickle Cell Disease (SCD). Sickle Cell Disease represents the second highest readmitting diagnosis at Houston Methodist Hospital. The purpose of this study is to determine the impact of implementing care coordination interventions to reduce hospital readmissions of patients with SCD.

PICOT

In adult patients with SCD in the acute care hospital setting, how does care coordination intervention compared to no care coordination intervention affect the readmission rate for patients with SCD over a 3 – 6-month period?

Body of Evidence

Eleven studies were critical appraised and included in the …


Clinical Decision Science: Proof Of Concept, James Peter Meza Md, Phd, Nicholus Yee Md, Bennett Riddering Md, Ali Nasrallah Md, Urtė Zableckas Ms, Mbbs Nov 2020

Clinical Decision Science: Proof Of Concept, James Peter Meza Md, Phd, Nicholus Yee Md, Bennett Riddering Md, Ali Nasrallah Md, Urtė Zableckas Ms, Mbbs

Clinical Research in Practice: The Journal of Team Hippocrates

Clinical decision science, a newly identified area of scholarship, describes how clinical research is used for a patient, within the context of their unique social conditions. We hypothesize that physicians use sociocultural context as an important input to their decision making. We performed a prospective, randomized, double-blind mixed methods study. Family medicine faculty and residents at a community hospital family medicine residency were included in the study. After academic journal club discussing a primary research paper, physicians were asked if they would prescribe medication for a patient who was similar to the subjects in a research paper. However, social and …


Implementing Inter-Professional Patient-Family Centered Plan Of Care Meetings On An Inpatient Hospital Unit, Nicolas Hernandez, Alice Fornari, Sage Rose, Leanne Tortez Apr 2020

Implementing Inter-Professional Patient-Family Centered Plan Of Care Meetings On An Inpatient Hospital Unit, Nicolas Hernandez, Alice Fornari, Sage Rose, Leanne Tortez

Patient Experience Journal

Inpatient plan of care meetings support efforts to encourage collaborative practice and patient-family centered care and result in an effective strategy to enhance communication and patient satisfaction. Clinical team members participated in patient/family centered plan of care meetings at a community hospital in a selected inpatient unit with full time hospitalist physicians. Quantitative data were gathered pre/post implementation from the external Hospital Consumer Assessment of Health Care Providers (HCAHPS) survey. HCAHPS data were collected independently, specifically for questions related to communication between patients, family members/guardians and the medical team and also the effects of care transition. There was a slow …


Bridging The Synapse: Seeing The World Through A Neuroscience Lens, Madeline Macarthur May 2019

Bridging The Synapse: Seeing The World Through A Neuroscience Lens, Madeline Macarthur

Chancellor’s Honors Program Projects

No abstract provided.


Understanding Regenerative Medicine And Its Position In Healthcare, Tyler F. Ward Jun 2018

Understanding Regenerative Medicine And Its Position In Healthcare, Tyler F. Ward

Kentucky Journal of Undergraduate Scholarship

Abstract: Regenerative medicine is an emerging field of the healthcare industry that has the potential to treat a myriad of health conditions. Induced pluripotent stem cells, human embryonic stem cells, and tissue engineering are a few of the treatment methods that may be delivered by healthcare professionals in personalized medicine. Food and Drug Administration (FDA) approval is necessary within the United States before any of these treatment options are available. Specific cellular therapies are currently undergoing clinical trials and it may be years before approval is acquired. The National Institute of Health is proactively working to ensure that healthcare policies, …